1 Gaps in communication between different staff groups and older adult patients foster unnecessary antibiotic prescribing for urinary tract infections in hospitals: a qualitative translation approach.

2 GPs' attitudes towards the diagnosis and treatment of male urinary tract infections: a qualitative interview study in Ireland.

3 Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections.

4 treinamento esfincteriano: métodos, expectativas dos pais e morbidades associadas toilet training: methods, parental expectations and associated dysfunctions

5 spontaneous resolution of vesicoureteral reflux (vur) in iranian children, a single center experience in 533 cases

6 pathogen distribution and drug resistance of nephrology patients with urinary tract infections

7 antimicrobial susceptibility of community-acquired uropathogens in general practice

8 infecciones tempranas en pacientes trasplantados en un hospital de alta complejidad

9 susceptibility trends and molecular characterization of gram-negative bacilli associated with urinary tract and intra-abdominal infections in jordan and lebanon: smart 2011–2013

10 virulence markers of vancomycin resistant enterococci isolated from infected and colonized patients

11 urinary tract infection with pasteurella multocida in a patient with cat exposure and abnormal urinary tract physiology: case report and literature review

12 caracterización clínica e imagenológica de niños y niñas con malformaciones urogenitales imaging and clinical characterization of children with urogenital malformations

13 Uropathogens and Gestational Outcomes of Urinary Tract Infections in Pregnancies that Necessitate Hospitalization.

14 Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: Case report and review of the literature.

15 Community acquired urinary tract infections among adults in Accra, Ghana

16 Virulence-associated genes and drug susceptibility patterns of uropathogenic Escherichia coli isolated from patients with urinary tract infection

17 In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

18 Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

19 Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study

20 Characterization of a NDM-7 carbapenemase-producing Escherichia coli ST410 clinical strain isolated from a urinary tract infection in China

21 Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community-acquired urinary tract infections and catheter-associated urinary tract infections

22 Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study

23 Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial

24 Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study

25 The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

26 Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum β-lactamases causing bacteremia and urinary tract infection in Manhiça, Mozambique

27 Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

28 Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

29 Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children

30 Antibiotic sensitivity pattern of uropathogens from pregnant women with urinary tract infection in Abakaliki, Nigeria

31 Procalcitonin as a useful marker to decide upon intervention for urinary tract infection

32 Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran

33 Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections

34 Community acquired urinary tract infections among adults in Accra, Ghana

35 Virulence-associated genes and drug susceptibility patterns of uropathogenic Escherichia coli isolated from patients with urinary tract infection

36 In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

37 Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

38 Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study

39 Characterization of a NDM-7 carbapenemase-producing Escherichia coli ST410 clinical strain isolated from a urinary tract infection in China

40 Community acquired urinary tract infections among adults in Accra, Ghana

41 Virulence-associated genes and drug susceptibility patterns of uropathogenic Escherichia coli isolated from patients with urinary tract infection

42 In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

43 Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

44 Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study

45 Characterization of a NDM-7 carbapenemase-producing Escherichia coli ST410 clinical strain isolated from a urinary tract infection in China

46 Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections

47 Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community-acquired urinary tract infections and catheter-associated urinary tract infections

48 Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study

49 Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial

50 Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study

51 The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

52 Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum β-lactamases causing bacteremia and urinary tract infection in Manhiça, Mozambique

53 Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

54 Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

55 Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children

56 Antibiotic sensitivity pattern of uropathogens from pregnant women with urinary tract infection in Abakaliki, Nigeria

57 Procalcitonin as a useful marker to decide upon intervention for urinary tract infection

58 Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran

59 Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections

60 Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study.

61 Reducing the incidence of pregnancy-related urinary tract infection by improving the knowledge and preventive practices of pregnant women.

62 Does antimicrobial coating and impregnation of urinary catheters prevent catheter-associated urinary tract infection? A review of clinical and preclinical studies.

63 Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection

64 Variable selection in covariate dependent random partition models: an application to urinary tract infection.

65 Catheter-Associated Urinary Tract Infections in Adults: Diagnosis, Treatment, and Prevention.

66 [An epidemiologic study of the antibiotic susceptibility of bacteria isolated from patients with urinary tract infections].

67 [Single-dose amoxicillin, TMP-SMX and ofloxacin therapy in lower urinary tract infections].

68 Failure of urinary beta-glucuronidase activity to localize the site of urinary tract infection

69 Preventing Catheter-Associated Urinary Tract Infections in the Pediatric Intensive Care Unit.

70 Urinary tract infections and affecting factors detected in tobb university of economics and technology faculty of medicine hospital: A 5-year retrospective study

71 Extended Abstract: Multicenter Comparison of Safety and Efficacy of Cefprozil vs. Cefaclor in the Treatment of Acute and Uncomplicated Urinary Tract Infections

72 Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!

73 A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections

74 Use of Quinolones in Urinary Tract Infections and Prostatitis

75 A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections

76 Temporal Changes in the Prevalence of Community-Acquired Antimicrobial-Resistant Urinary Tract Infection Affected by Escherichia coli Clonal Group Composition

77 An Approach to Evaluating Antibacterial Agents in the Treatment of Urinary Tract Infection

78 Prevalence and predictors of urinary tract infection and severe malaria among febrile children attending Makongoro health centre in Mwanza city, North-Western Tanzania

79 Prevalence and predictors of urinary tract infection and severe malaria among febrile children attending Makongoro health centre in Mwanza city, North-Western Tanzania

80 nursing actions to prevent urinary tract infection associated with long-standing bladder catheter

81 reliability and validity of a chinese version of urinary tract infection symptom assessment questionnaire

82 evaluating children with otitis media for bacteremia or urinary tract infection

83 urinary tract infection due to chryseobacterium gleum, an uncommon pathogen

84 correlation between urine analysis and urine culture in the diagnosis of urinary tract infection in yazd central laboratory

85 risk factors for postoperative urinary tract infections in patients undergoing total joint arthroplasty

86 antimicrobial susceptibility patterns among escherichia coli urinary isolates from community-onset health care-associated urinary tract infection

87 incidence and antibiotic susceptibility pattern of most common bacterial pathogen causing urinary tract infection (uti) in tehran, iran, 2012-2013

88 complicated urinary tract infection caused by extended spectrum β-lactamase-producing escherichia coli

89 bacteremic renal stone-associated urinary tract infection caused by nontypable haemophilus influenzae: a rare invasive disease in an immunocompetent patient

90 cranberries for preventing urinary tract infections

91 extended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in são luís, brazil

92 biofilm formation capability of enterococcal strains causing urinary tract infection vis-a-vis colonisation and correlation with enterococcal surface protein gene

93 time-based distribution of staphylococcus saprophyticus pulsed field gel-electrophoresis clusters in community-acquired urinary tract infections

94 high-throughput method for antibiotic susceptibility testing based on fluorescein quenching by bacteria: application to urinary tract infection

95 antimicrobial resistance pattern of escherichia coli isolated from patients with urinary tract infection (uti) in yasuj city during 1391-1392.

96 the tir domain containing locus of enterococcus faecalis is predominant among urinary tract infection isolates and downregulates host inflammatory response

97 long-term efficacy of fulguration of trigonitis for recurrent urinary tract infections in women

98 an exceptional source of recurrent urinary tract infections in women: primary retroperitoneal serous cystadenoma

99 cephradine-a new cephalosporin in recurrent urinary tract infection

100 antibiotic resistant urinary tract infections in an urology ward

101 onychomycosis: a rare presentation of fungal urinary tract infection in an extremely preterm neonate

Keyword Connections

Journals

Research Groups

Bibliographies